Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Objective sleepiness without a subjective complaint decreases hypertension risk
Nikolaos Athanasiou1,2, Slobodanka Pejovic1, Julio Fernandez-Mendoza1
1Sleep Research and Treatment Center, Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey, PA, United States.
Objective sleepiness, without excessive daytime sleepiness (EDS), may protect against hypertension. This finding suggests a potential benefit for clinicians assessing cardiovascular risk in patients.
Area of Science:
- Cardiology
- Sleep Medicine
- Public Health
Background:
- Excessive daytime sleepiness (EDS) is linked to cardiovascular issues.
- Objective sleepiness (short sleep onset latency, SOL) is linked to cognitive deficits but not cardiovascular risk.
- The association between objective sleepiness without EDS and hypertension risk is unexplored.
Purpose of the Study:
- To investigate the association between objective sleepiness without EDS and hypertension risk.
- To analyze this association in a large, general population sample.
Main Methods:
- Cross-sectional and longitudinal analyses of 1590 adults from the Penn State Cohort without EDS.
- Objective sleepiness defined as SOL ≤ 7 minutes via polysomnography.
- Hypertension assessed as prevalent (high blood pressure or medication) and incident (new treatment).
Main Results:
- Objective sleepiness was associated with lower prevalence (22.1% vs. 32.3%) and incidence (8.8% vs. 17.3%) of hypertension.
- Individuals with objective sleepiness had reduced odds of prevalent (OR=0.44) and incident (OR=0.31) hypertension.
- Combining objective sleepiness with EDS negated the protective effect against hypertension.
Conclusions:
- Objective sleepiness, in the absence of EDS, demonstrates a protective association with hypertension risk.
- These findings offer valuable insights for clinicians in evaluating hypertension risk.
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sleep Apnea
The condition is more prevalent among...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Management of Insomnia

